Google DeepMind CEO Demis Hassabis has said that AI can have a serious crack at solving all diseases in the coming years. And ...

Out to make a bigger difference, Alphabet’s Isomorphic Labs is exploring a much more useful application of AI. The Google ...

ICE Raids Derail Los Angeles Economy as Workers Go Into Hiding Texas Floods Inundate Central Areas As Waters Seen Rising ...

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

European technology companies are commanding attention on the global stage, with several securing massive funding rounds that ...

Trump’s new COVID-19 website features five arguments supporting the lab. Among them was the explanation that Wuhan – the Chinese city where the virus first began spreading – is home to a ...

The Graph Isomorphism problem regained interest with the rise of Graph Neural Networks (GNN). These GNN models have limited ability to distinguish between isomorphic graphs and hence their outputs are ...